Sobi and Handok establish joint venture for rare disease business in South Korea
· A long-term strategic partnership model is being developed through a joint venture. · The joint venture will commercialise and distribute selected Sobi medicines in South KoreaSobi® and Handok will establish a joint venture for the rare disease business in South Korea. The joint venture, due for incorporation in the first half of this year, is expected to enhance the Sobi and Handok collaboration. Strengthening their position in the rare disease business, Handok and Sobi aim to develop, commercialise and distribute Sobi’s innovative medicines in South Korea.Serving patients in South